KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Long-Term Debt Repayments (2017 - 2023)

Biolife Solutions (BLFS) has disclosed Long-Term Debt Repayments for 6 consecutive years, with $129000.0 as the latest value for Q2 2023.

  • On a quarterly basis, Long-Term Debt Repayments rose 5.74% to $129000.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $9000.0, a 96.36% decrease, with the full-year FY2018 number at $13000.0, up 18.18% from a year prior.
  • Long-Term Debt Repayments was $129000.0 for Q2 2023 at Biolife Solutions, up from $127000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.5 million in Q3 2022 to a low of -$2.2 million in Q4 2020.
  • A 4-year average of -$213702.2 and a median of $122000.0 in 2022 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: tumbled 200.0% in 2019, then skyrocketed 92.0% in 2020.
  • Biolife Solutions' Long-Term Debt Repayments stood at -$4000.0 in 2019, then plummeted by 54275.0% to -$2.2 million in 2020, then rose by 19.54% to -$1.8 million in 2022, then skyrocketed by 107.37% to $129000.0 in 2023.
  • Per Business Quant, the three most recent readings for BLFS's Long-Term Debt Repayments are $129000.0 (Q2 2023), $127000.0 (Q1 2023), and -$1.8 million (Q4 2022).